These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 676876

  • 1. [Microbiology and pharmacokinetics of gentamicin, sisomicin, netilmicin and amikacin].
    Naumann P, Rosin H.
    Adv Clin Pharmacol; 1978; 15():23-34. PubMed ID: 676876
    [No Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetics of lividomycin, aminkacin and sisomicin in patients with chronic renal insufficiency].
    Leroy A, Oksenhendler G, Fillastre JP, Humbert G.
    J Urol Nephrol (Paris); 1977 Sep; 83(9):738-41. PubMed ID: 243544
    [No Abstract] [Full Text] [Related]

  • 3. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
    Seligman SJ.
    Antimicrob Agents Chemother; 1978 Jan; 13(1):70-3. PubMed ID: 626492
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC, Ehret JM.
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [Abstract] [Full Text] [Related]

  • 5. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R, Hajsig D, Babić I, Mostovac D.
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I, Voeckl J, Machka K.
    Arzneimittelforschung; 1980 Nov; 30(3):491-5. PubMed ID: 7387761
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J, Legakis NJ, Nicolas KJ, Melissinos K, Papavassiliou J.
    Chemotherapy; 1980 Nov; 26(6):409-17. PubMed ID: 7408554
    [Abstract] [Full Text] [Related]

  • 8. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.
    Xerri L, Orsolini P, Broggio R.
    Chemioterapia; 1984 Oct; 3(5):271-7. PubMed ID: 6398124
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.
    Pogwizd SM, Lerner SA.
    Antimicrob Agents Chemother; 1976 Dec; 10(6):878-84. PubMed ID: 795373
    [Abstract] [Full Text] [Related]

  • 10. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
    Knothe H, Krcméry V.
    Chemotherapy; 1979 Dec; 25(1):23-9. PubMed ID: 105839
    [No Abstract] [Full Text] [Related]

  • 11. Comparative pharmacokinetics of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients.
    Leroy A, Humbert G, Oksenhendler G, Fillastre JP.
    J Antimicrob Chemother; 1976 Dec; 2(4):373-81. PubMed ID: 1052072
    [No Abstract] [Full Text] [Related]

  • 12. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ, Simberkoff MS, Kagan K, Moldover NH.
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [Abstract] [Full Text] [Related]

  • 13. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP, Neu HC.
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [Abstract] [Full Text] [Related]

  • 14. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I, Tunevall G.
    Scand J Infect Dis Suppl; 1980 Feb; Suppl 23():39-44. PubMed ID: 6782657
    [Abstract] [Full Text] [Related]

  • 15. Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.
    Brummett RE, Fox KE, Bendrick TW, Himes DL.
    J Antimicrob Chemother; 1978 May; 4 Suppl A():73-83. PubMed ID: 659353
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of netilmicin.
    Smith JA, Morgan JR, Mogyoros M.
    Antimicrob Agents Chemother; 1977 Feb; 11(2):362-4. PubMed ID: 848942
    [Abstract] [Full Text] [Related]

  • 17. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R, Azanza Perea JR, Echeverría Echepare LM, Honorato Pérez J.
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract] [Full Text] [Related]

  • 18. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H, Patzer J.
    Med Dosw Mikrobiol; 1984 Dec; 36(4):223-9. PubMed ID: 6100122
    [No Abstract] [Full Text] [Related]

  • 19. Sisomicin: in vitro activity and pharmacokinetics.
    Simon C, Maleryzk V, Ahlendorf W.
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):145-9. PubMed ID: 649233
    [Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H, Naumann P, Reintjens E, Köhler M.
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.